Having keen market understanding and vast experience in this field we are engaged in offering our clients Geftinat Gefitinib Tablet. It is classified as a protein kinase inhibitor and widely used in cancer treatment purposes. Tablet is procured from trusted vendors of the market by our agents. It is indicated for the treatment of non-small cell lung cancer in adult patients. Geftinat Gefitinib Tablet blocks the protein that is involved in the growth and spread of cancer cells.